The latest fund announced Tuesday is the firm’s first raise in five years and third overall, and includes both new and existing investors.

Breakout Ventures is finding growing success by backing early-stage startups in scientific fields such as biology and chemistry. 

The venture capital firm has $114 million to invest

In this series, we shine a spotlight on managers in the 100 Women In Finance FundWomen Directory, showcasing female-led funds from across asset classes and geographies. This week, we meet FundWomen Ma...

Lessons from Breakout’s inaugural Founder Outpost

Sometimes research needs to leave academia in order to thrive. Three spin-off founders reveal key drivers of their success.

Noetik will use its multimodal AI models to identify which patients will most likely benefit from Agenus’s lead immuno-oncology combination, BOT/BAL.

Activewear relies on synthetics. But as innovators bring stretch denim alternatives to market, important learnings for the sportswear sector could surface.

The chemical industry is at a turning point, and Copernic Catalysts is building the technology to lead it—next-generation catalysts that reduce costs, lower emissions, and unlock step-change efficienc...

YouTube video by Austin For America

The Tech Tribune staff has compiled the very best tech startups in Minnesota. In doing our research, we considered several factors

Modern Meadow CEO David Williamson shares how biofabrication is shaking up the world of materials.

The Chicago-based carrier has partnered with a number of clean-tech startups in recent months in an effort to meet its climate goals

/PRNewswire/ -- A retrospective analysis of an observational study being presented this week at the Society of Hospital Medicine (SHM) Converge conference...

Noetik powers precision cancer therapies with machine learning

Checkerspot has developed a Non GMO algal oil in a fermentation tank with the performance of high-oleic palm oil.

Why Breakout invested in Phantom Neuro, again

The science fiction trope of humans superpowered by computer and bionic implants is fast becoming a reality, and today, a startup hoping for a role in how that plays out is announcing some funding.  Phantom Neuro, which is developing a wristband-like device that gets implanted under the skin to let a person control prosthetic limbs, […]

Athletic apparel company lululemon has entered into a multi-year collaboration agreement with California-based biotechnology firm ZymoChem aimed at expanding the use of sustainable bio-based nylon in ...

In this episode of FoodNavigator-USA’s Soup-To-Nuts podcast, Krzywicki shares his vision for Checkerspot as the new CEO and how under his leadership the company plans to address some of the biggest ch...

The Trump administration’s plans to reduce NIH grant funding could have long-term consequences for the U.S. drug industry, investors said.

EnPlusOne Biosciences, Inc., a biotechnology company harnessing the power of enzymes to deliver better RNA at scale, today announced that it had raise

Startup Canaery is partnering with a US Department of Energy lab to develop neural implants for rats and dogs that are capable of decoding what they smell.

Twelve has secured an additional $83 million in Series C and project funding, advancing its mission to replace fossil fuels with CO2-derived materials.

YouTube video by Modev

In this episode, I'm joined by Ron Alfa, Co-Founder and CEO of Noetik, to discuss the groundbreaking role of foundation models in advancing cancer immunotherapy.

/PRNewswire/ -- Cytovale®, a commercial-stage medical diagnostics company, today celebrated a monumental year that catapulted it to lead the emerging sepsis...

Read article about While price and quality remain key for consumers buying home items, manufacturers are increasingly focused on materials. Meanwhile, volume specifiers and buyers in the contract home...

Sean Ainsworth, CEO of Immusoft, about MPS I, the limits of existing enzyme replacement therapies, and the potential benefits of using engineered B cells to treat people with the rare lysosomal storag...

Startup Phantom Neuro is building an implant that sits under the skin and promises to give amputees more accurate control of electronic prosthetics.

Many VCs, particularly newer firms, readily admit that 2024 has been a challenging year for raising fresh capital. Dimension Capital, a two-year-old

ShiraTronics announced that it initiated its FDA investigational device exemption (IDE) pivotal trial for its neuromodulation therapy.